Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Operating Leases (2019 - 2025)

Historic Operating Leases for Rockwell Medical (RMTI) over the last 10 years, with Q3 2025 value amounting to $3.0 million.

  • Rockwell Medical's Operating Leases fell 1670.32% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year decrease of 1670.32%. This contributed to the annual value of $1.7 million for FY2024, which is 1856.25% up from last year.
  • Rockwell Medical's Operating Leases amounted to $3.0 million in Q3 2025, which was down 1670.32% from $3.5 million recorded in Q2 2025.
  • Rockwell Medical's 5-year Operating Leases high stood at $7.4 million for Q1 2022, and its period low was $1.4 million during Q4 2023.
  • For the 5-year period, Rockwell Medical's Operating Leases averaged around $4.3 million, with its median value being $3.7 million (2024).
  • In the last 5 years, Rockwell Medical's Operating Leases skyrocketed by 22328.39% in 2021 and then crashed by 5615.76% in 2022.
  • Over the past 5 years, Rockwell Medical's Operating Leases (Quarter) stood at $5.9 million in 2021, then plummeted by 56.16% to $2.6 million in 2022, then tumbled by 44.48% to $1.4 million in 2023, then rose by 18.56% to $1.7 million in 2024, then soared by 79.05% to $3.0 million in 2025.
  • Its last three reported values are $3.0 million in Q3 2025, $3.5 million for Q2 2025, and $2.9 million during Q1 2025.